Tesaro: Top 5 Biotech VC deals, H1 2010

Company: Tesaro
Based: Boston, MA
Amount: $60M

Investors: New Enterprise Associates, Tesaro management

Scoop: Two years after Eisai bought MGI Pharma for $3.9 billion, a group of former MGI Pharma execs joined together to found Tesaro. In May, the tiny company landed $60 million in start-up funding to acquire, develop and commercialize cancer therapeutics and supportive care products. New Enterprise Associates forked over $20 million in start-up funding and has reserved $40 million to support company growth.

Related Articles:
Eisai expands U.S. ops with $3.9B MGI buyout
MGI alum garner $60M to launch new cancer drug developer